crispr therapeutics, mgh team up on new cancer treatments .
"we were quite surprised to find there were no significant differences," says study author .
-
.
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
1243 Used Today
884 Used Today
318 Used Today
99 Used Today
110 Used Today
273 Used Today
323 Used Today
"we were quite surprised to find there were no significant differences," says study author .
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
218 Used Today